Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey - PubMed (original) (raw)

. 2013 Sep;11(9):1183-1190.e2.

doi: 10.1016/j.cgh.2013.02.011. Epub 2013 Feb 13.

Jody McLean, Mariana Lazo, Frederick L Brancati, Joel N Hirschhorn, Ingrid B Borecki, Tamara B Harris; Genetics of Obesity-Related Liver Disease (GOLD) Consortium; Thutrang Nguyen, Ihab R Kamel, Susanne Bonekamp, Mark S Eberhardt, Jeanne M Clark, Wen Hong Linda Kao, Elizabeth K Speliotes

Affiliations

Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey

Ruben Hernaez et al. Clin Gastroenterol Hepatol. 2013 Sep.

Abstract

Background & aims: A genome-wide association study associated 5 genetic variants with hepatic steatosis (identified by computerized tomography) in individuals of European ancestry. We investigated whether these variants were associated with measures of hepatic steatosis (HS) in non-Hispanic white (NHW), non-Hispanic black, and Mexican American (MA) participants in the US population-based National Health and Nutrition Examination Survey III, phase 2.

Methods: We analyzed data from 4804 adults (1825 NHW, 1442 non-Hispanic black, and 1537 MA; 51.7% women; mean age at examination, 42.5 y); the weighted prevalence of HS was 37.3%. We investigated whether ultrasound-measured HS, with and without increased levels of alanine aminotransferase (ALT), or level of ALT alone, was associated with rs738409 (patatin-like phospholipase domain-containing protein 3 [PNPLA3]), rs2228603 (neurocan [NCAN]), rs12137855 (lysophospholipase-like 1), rs780094 (glucokinase regulatory protein [GCKR]), and rs4240624 (protein phosphatase 1, regulatory subunit 3b [PPP1R3B]) using regression modeling in an additive genetic model, controlling for age, age-squared, sex, and alcohol consumption.

Results: The G allele of rs738409 (PNPLA3) and the T allele of rs780094 (GCKR) were associated with HS with a high level of ALT (odds ratio [OR], 1.36; P = .01; and OR, 1.30; P = .03, respectively). The A allele of rs4240624 (PPP1R3B) and the T allele of rs2228603 (NCAN) were associated with HS (OR, 1.28; P = .03; and OR, 1.40; P = .04, respectively). Variants of PNPLA3 and NCAN were associated with ALT level among all 3 ancestries. Some single-nucleotide polymorphisms were associated with particular races or ethnicities: variants in PNPLA3, NCAN, GCKR, and PPP1R3B were associated with NHW and variants in PNPLA3 were associated with MA. No variants were associated with NHB.

Conclusions: We used data from the National Health and Nutrition Examination Survey III to validate the association between rs738409 (PNPLA3), rs780094 (GCKR), and rs4240624 (PPP1R3B) with HS, with or without increased levels of ALT, among 3 different ancestries. Some, but not all, associations between variants in NCAN, lysophospholipase-like 1, GCKR, and PPP1R3B with HS (with and without increased ALT level) were significant within subpopulations.

Keywords: ALT; AST; Candidate Gene Study; EAF; GCKR; Genome-wide Association Study; HDL-c; HS; LYPLAL1; MA; Mexican American; NAFLD; NASH; NCAN; NHANES III; NHB; NHW; Nonalcoholic Fatty Liver Disease; OR; PNPLA3; PPP1R3B; Replication; SNP; Third National Health and Nutrition Examination Survey; alanine aminotransferase; aspartate aminotransferase; effect allele frequency; glucokinase regulatory protein; hepatic steatosis; high-density lipoprotein cholesterol; lysophospholipase-like 1; neurocan; non-Hispanic black; non-Hispanic white; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; odds ratios; patatin-like phospholipase domain-containing protein 3; protein phosphatase 1, regulatory subunit 3b; single-nucleotide polymorphisms.

Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors disclose no conflicts.

Figures

Figure 1

Figure 1

Flow chart of the National Health and Nutrition Examination Survey, phase 2 (1991–1994).

Figure 2

Figure 2

Association between HS and different SNPs, stratified by ethnicity in the NHANES III (1991–1994), population-weighted, additive model, adjusted for age, age squared, sex, and alcohol consumption.

Figure 3

Figure 3

Association between HS with high ALT level and different SNPs, stratified by ethnicity in the NHANES III (1991–1994), population-weighted, additive model, adjusted for age, age squared, sex, and alcohol consumption.

Comment in

References

    1. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–241. - PubMed
    1. Adams LA, Waters OR, Knuiman MW, et al. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol. 2009;104:861–867. - PubMed
    1. American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1702–1704. - PubMed
    1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–1231. - PubMed
    1. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA. 2003;289:3000–3004. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources